The National MS Society is reporting that an Italian study of more than 2,500 people with MS shows that early interferon therapy treatment offered a significant reduction in the risk of the progression of multiple sclerosis.

Read the MS Society news release here.

The study followed the relapsing-remitting patients being treated with any type of interferon beta for up to 7 years, with a median time of 4 1/2 year period. They tracked the patients every 6 monghs, measuring physical disability. Early treatment was defined as less than or up to one year from the onself of the disease. Treatment administered more than one year after onset was defined as delayed treatment.

Early treatment was found to significantly reduce the progression of the disease as compared to delayed treatment starts.

Related articles by Zemanta

• Smoking Worsens Multiple Sclerosis (nlm.nih.gov)
• MS is more aggressive in children but slower to cause disability than in adults (scienceblog.com)

This entry was posted on Sunday, December 20th, 2009 at 10:00 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.